Price Chart

Profile

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
URL https://www.trinitybiotech.com
Investor Relations URL http://www.trinitybiotech.com/investor-relations/
HQ State/Province N/A
Sector Health Care
Industry Health Care Equipment & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Jan. 31, 2025 (est.)
Last Earnings Release Aug. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 05, 2015

Profile

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
URL https://www.trinitybiotech.com
Investor Relations URL http://www.trinitybiotech.com/investor-relations/
HQ State/Province N/A
Sector Health Care
Industry Health Care Equipment & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Jan. 31, 2025 (est.)
Last Earnings Release Aug. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 05, 2015